Symbol="ADXN"
AssetType="Common Stock"
Name="Addex Therapeutics Ltd"
Description="Addex Therapeutics Ltd, a developing-stage biopharmaceutical company, discovers, develops and markets small molecule pharmaceuticals for central nervous system (CNS) disorders in Switzerland. The company is headquartered in Geneva, Switzerland."
CIK="1574232"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="CHEMIN DES MINES 9, GENEVA, CH"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="11287700"
EBITDA="-17205740"
PERatio="None"
PEGRatio="None"
BookValue="0.384"
DividendPerShare="0"
DividendYield="0"
EPS="-2.21"
RevenuePerShareTTM="0.198"
ProfitMargin="0"
OperatingMarginTTM="-10.07"
ReturnOnAssetsTTM="-0.859"
ReturnOnEquityTTM="-2.042"
RevenueTTM="1703100"
GrossProfitTTM="1445000"
DilutedEPSTTM="-2.21"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="1.058"
AnalystTargetPrice="None"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="10.28"
PriceToBookRatio="1.409"
EVToRevenue="2.539"
EVToEBITDA="-0.147"
Beta="1.669"
num_52WeekHigh="2.28"
num_52WeekLow="0.422"
num_50DayMovingAverage="0.672"
num_200DayMovingAverage="0.887"
SharesOutstanding="16995700"
DividendDate="None"
ExDividendDate="None"
symbol="ADXN"
open="0.60"
high="0.60"
low="0.54"
price="0.57"
volume="76372.00"
latest_trading_day="2023-07-21"
previous_close="0.57"
change="0.00"
change_percent="0.4724%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="74"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="26"
Volume_recent_avg="374537"
Change_recent_avg="-0.02"
Delta_recent_avg="0.1"
Variance_recent_avg="0.05"
Change_ratio_recent_avg="-2.18"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="26"
Aroon_momentum_negative="74"
image_negative_thumbnail_id_1="515"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0090.jpeg"
image_negative_thumbnail_id_2="131"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0045.jpeg"
image_neutral_thumbnail_id_1="591"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0008.jpeg"
image_neutral_thumbnail_id_2="549"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0050.jpeg"
image_positive_thumbnail_id_1="670"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0038.jpeg"
image_positive_thumbnail_id_2="646"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0062.jpeg"
image_professor_thumbnail_id_1="1180"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0014.jpeg"
image_professor_thumbnail_id_2="1173"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0007.jpeg"
